From the pharmacological standpoint, the development of these inhibitors could provide new avenues of research to develop targeted therapies aimed at inhibiting cancer cell proteostasis while impacting their overall phenotype since they showed to affect cell migration and increasing adhesion and expression of E-Cadherin. The gene discussed is CDH1; the disease is cancer.